February 21, 2018 / 12:18 PM / 6 months ago

BRIEF-Blueprint Medicines Q4 Loss Per Share $1.23

Feb 21 (Reuters) - Blueprint Medicines Corp:

* BLUEPRINT MEDICINES REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $1.23

* Q4 EARNINGS PER SHARE VIEW $-1.11 -- THOMSON REUTERS I/B/E/S

* BLUEPRINT MEDICINES - EXPECTS EXISTING CASH, CASH EQUIVALENTS AND INVESTMENTS TO FUND OPERATING EXPENSES, CAPITAL EXPENDITURES INTO MIDDLE OF 2020

* AS OF DEC 31, 2017, CASH, CASH EQUIVALENTS AND INVESTMENTS OF $673.4 MILLION, VERSUS $268.2 MILLION AS OF DEC 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below